Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bubley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Virology|August 1, 1985
Inhibition of HSV-transformed murine cells by nucleoside analogs, 2'-NDG and 2'-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosidesS Oliver, G Bubley, C Crumpacker
Oncogene|January 28, 1998
Frequent abnormalities of TSG101 transcripts in human prostate cancerZ Sun, J Pan, G Bubley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Hormonal predictors of prostate cancer: a meta-analysisT Shaneyfelt, R Husein, G Bubley, et al.
Virology|September 1, 1983
Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cellsG Bubley, C Crumpacker, E De Clercq, et al.
American Journal of Hematology|April 1, 1983
Pericardial tamponade associated with myeloid metaplasiaG Bubley, P Come, D MacDougall, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Combination of etanidazole with cyclophosphamide and platinum complexesB A Teicher, T S Herman, L Shulman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonistsS A Stoch, R A Parker, L Chen, et al.
Cancer Research|February 15, 1991
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinomaB A Teicher, T S Herman, J Tanaka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Detection of circulating tumor cells in men with localized prostate cancerM V Seiden, P W Kantoff, K Krithivas, et al.
Annals of Internal Medicine|November 1, 1987
Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferationC Crumpacker, W Heagy, G Bubley, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Virology|August 1, 1985
Inhibition of HSV-transformed murine cells by nucleoside analogs, 2'-NDG and 2'-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosidesS Oliver, G Bubley, C Crumpacker
Oncogene|January 28, 1998
Frequent abnormalities of TSG101 transcripts in human prostate cancerZ Sun, J Pan, G Bubley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Hormonal predictors of prostate cancer: a meta-analysisT Shaneyfelt, R Husein, G Bubley, et al.
Virology|September 1, 1983
Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cellsG Bubley, C Crumpacker, E De Clercq, et al.
American Journal of Hematology|April 1, 1983
Pericardial tamponade associated with myeloid metaplasiaG Bubley, P Come, D MacDougall, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Combination of etanidazole with cyclophosphamide and platinum complexesB A Teicher, T S Herman, L Shulman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonistsS A Stoch, R A Parker, L Chen, et al.
Cancer Research|February 15, 1991
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinomaB A Teicher, T S Herman, J Tanaka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Detection of circulating tumor cells in men with localized prostate cancerM V Seiden, P W Kantoff, K Krithivas, et al.
Annals of Internal Medicine|November 1, 1987
Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferationC Crumpacker, W Heagy, G Bubley, et al.
Pageof 2